TransCode Therapeutics (RNAZ) News Today

→ Biden out June 13; Kamala won’t replace him? (From Paradigm Press) (Ad)

$0.50

-0.03 (-5.61%)

(As of 04/16/2024 ET)

Source

Source	Headline
	TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors globenewswire.com - April 15 at 9:00 AM
	FY2024 EPS Estimates for TransCode Therapeutics, Inc. Increased by Analyst (NASDAQ:RNAZ) americanbankingnews.com - April 8 at 1:52 AM
	Analysts Issue Forecasts for TransCode Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:RNAZ) americanbankingnews.com - April 6 at 1:22 AM
	Promising Phase 0 Results and Upcoming Trial Boost Confidence in TransCode Therapeutics markets.businessinsider.com - April 4 at 2:37 AM
	TransCode Therapeutics Reports 2023 Results; Provides Business Update globenewswire.com - April 3 at 9:10 AM
	TransCode Therapeutics appoints new Chief Medical Officer uk.investing.com - March 30 at 4:57 PM
	TransCode Appoints Daniel Vlock As CMO markets.businessinsider.com - March 29 at 2:19 AM
	TransCode Therapeutics, Inc.: TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer finanznachrichten.de - March 28 at 11:16 AM
	TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer globenewswire.com - March 28 at 8:30 AM
	TransCode Therapeutics, Inc.: TransCode Therapeutics and Akribion Genomics Report Progress Developing CRISPR-Derived Technology for Cancer Treatment finanznachrichten.de - March 11 at 2:00 PM
	TransCode Therapeutics and Akribion Genomics Report Progress Developing CRISPR-Derived Technology for Cancer Treatment globenewswire.com - March 11 at 9:00 AM
	TransCode Therapeutics To Present At 2024 RNA Leaders Europe Congress globenewswire.com - March 6 at 4:15 PM
	TransCode Therapeutics Reports Publication of United States Patent Application Covering TransCode’s RIG-I Agonist Immunotherapeutic finance.yahoo.com - February 20 at 12:42 PM
	TransCode Therapeutics Reports Publication of United States Patent Application Covering TransCode's RIG-I Agonist Immunotherapeutic globenewswire.com - February 20 at 8:00 AM
	Transcode Therapeutics Inc (RNAZ) uk.investing.com - February 1 at 7:57 AM
	Nasdaq Determines TransCode Therapeutics Compliance with Minimum Stockholders’ Equity Requirement and Continued Listing on The Nasdaq Stock Market finance.yahoo.com - January 31 at 8:48 PM
	Looking Into TransCode Therapeutics's Recent Short Interest benzinga.com - January 30 at 7:38 AM
	TransCode Collaborates With Debiopharm; Financial Terms Not Disclosed markets.businessinsider.com - January 29 at 12:45 PM
	TransCode Therapeutics and Debiopharm Announce Collaboration to Develop Targeted Nucleic Acid Therapeutics for Cancer finance.yahoo.com - January 29 at 12:45 PM
	TransCode Therapeutics Announces Closing of $7.25 Million Public Offering finance.yahoo.com - January 22 at 6:20 PM
	Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session msn.com - January 19 at 2:23 PM
	TransCode Therapeutics Shares Slide to 52-Week Low on Planned Public Offering marketwatch.com - January 18 at 4:03 PM
	TransCode Therapeutics Announces Pricing of $7.25 Million Public Offering finance.yahoo.com - January 18 at 4:03 PM
	marketbeat.com - January 18 at 1:31 PM
	TransCode Therapeutics, Inc.: TransCode Therapeutics Announces 1-for-40 Reverse Stock Split finanznachrichten.de - January 15 at 11:43 PM
	marketbeat.com - January 15 at 6:07 AM
	TransCode Therapeutics Stock (NASDAQ:RNAZ) Dividends: History, Yield and Dates benzinga.com - January 14 at 8:56 AM
	Stocks to Watch: TransCode Therapeutics, Rackspace Technology, Williams-Sonoma marketwatch.com - January 12 at 7:52 PM
	TransCode Therapeutics announces retirement of CEO msn.com - January 12 at 7:52 PM
	TransCode Therapeutics Reports Further Restructuring to Reduce Expenses and Increased Focus on Planned Phase 1 Clinical Trial, Retirement of CEO finance.yahoo.com - January 12 at 7:52 PM
	TransCode Therapeutics Announces 1-for-40 Reverse Stock Split finance.yahoo.com - January 11 at 12:11 PM
	TransCode Therapeutics Publishes Open Letter Outlining Company’s Progress and Objectives finance.yahoo.com - January 4 at 10:16 AM
	TransCode Therapeutics Reports Positive Pre-Clinical Results in Metastatic Pancreatic Cancer with its Lead Candidate, TTX-MC138 finance.yahoo.com - December 12 at 8:58 AM
	TransCode Therapeutics Announces Closing of $1.2 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules finance.yahoo.com - December 4 at 7:10 PM
	TransCode Therapeutics Reports Third Quarter 2023 Results; Provides Business Update finance.yahoo.com - November 14 at 7:26 PM
	TransCode Therapeutics, Inc.: TransCode Therapeutics Withdraws Public Offering finanznachrichten.de - October 31 at 8:43 AM
	TransCode Therapeutics Withdraws Public Offering finance.yahoo.com - October 30 at 7:00 PM
	Nasdaq Panel Grants TransCode Therapeutics Extension for Continued Listing on The Nasdaq Stock Market Subject to Conditions finance.yahoo.com - October 27 at 12:00 PM
	Why Is TransCode Therapeutics (RNAZ) Stock Down 25% Today? investorplace.com - October 27 at 9:12 AM
	TransCode Therapeutics Announces Public Offering of Common Stock benzinga.com - October 26 at 8:13 PM
	TransCode Therapeutics Announces Public Offering of Common Stock finance.yahoo.com - October 26 at 8:13 PM
	TransCode Therapeutics Stock (NASDAQ:RNAZ), Analyst Ratings, Price Targets, Predictions benzinga.com - October 26 at 3:10 PM
	TransCode Therapeutics Announces Prolonged Survival in Murine Models with Glioblastoma Treated with Its Lead Candidate, TTX-MC138 finance.yahoo.com - October 26 at 8:22 AM
	Promising Preliminary Clinical and Preclinical Results Bolster Buy Rating for TransCode Therapeutics: An Analysis by Emily Bodnar markets.businessinsider.com - October 25 at 2:45 PM
	TransCode Therapeutics Reports Successful Treatment of Preclinical Melanoma Tumors with its Immunotherapy Candidate, TTX-RIGA finance.yahoo.com - October 16 at 12:37 PM
	TransCode Therapeutics, Inc.: TransCode Therapeutics Announces Closing of $8.5 Million Public Offering finanznachrichten.de - September 30 at 12:13 AM
	TransCode Therapeutics Announces Closing of $8.5 Million Public Offering finance.yahoo.com - September 28 at 6:53 PM
	Why Transcode Therapeutics (RNAZ) Stock Is Down Nearly 70% benzinga.com - September 26 at 2:06 PM
	Transcode Therapeutics stock whipsaws lower after cut price placing proactiveinvestors.com - September 26 at 9:06 AM
	Why Is TransCode Therapeutics (RNAZ) Stock Down 69% Today? msn.com - September 26 at 9:06 AM

Get TransCode Therapeutics News Delivered to You Automatically

The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

RNAZ Media Mentions By Week

RNAZ Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RNAZ
News Sentiment
▼
0.97

0.66
▲
Average
Medical
News Sentiment

RNAZ News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RNAZ Articles
This Week
▼
5

2
▲
RNAZ Articles
Average Week

Get TransCode Therapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:RNAZ) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

TransCode Therapeutics (RNAZ) News Today

RNAZ Media Mentions By Week

RNAZ Media Sentiment

RNAZ News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info